Drug Pricing

Commentary

Big Pharma Accomplishes Big Things, Yet Obama Is Suffocating The Industry

What’s the most research-intensive industry in America? If you guessed Silicon Valley or the energy sector, guess again. In fact, it’s the drug industry. The 31 pharmaceutical companies comprising its main trade group spent $48.5 billion on research and development last year. All told, the pharmaceutical sector has spent $550 …

Commentary

Why Are The Democrats Attacking The Only Successful Part Of Medicare

The much-discussed sequester has taken effect. But federal lawmakers are still trying to find ways to undo the $85 billion in spending cuts it has put in motion. In his state -of-the-union address, President Obama trained his eyes on one of his favorite bogeymen — the pharmaceutical industry. The president …

Commentary

Senior Citizens Will Pay Dearly For Health Care Price Controls

Squabbles over spending cuts have ruled the negotiations over increasing the debt ceiling. But even after the ink is dry on the budget deal just passed, lawmakers will still be charged with reducing federal spending further. One proposal that refuses to die would impose price controls on prescription drugs in …

Commentary

A Plan That Leads Health Care To Nowhere

President Obama recently offered up his plan for cutting the federal budget deficit by $4 trillion over 12 years. A big chunk of those proposed savings–$480 billion, or more than 10%–is supposed to come from federal health care programs. Unfortunately, the president plans to achieve those savings through heavy-handed rationing. …

Commentary

Obamacare Unintended Consequence of the Day: Higher Drug Prices for Kids’ Hospitals

One anonymous politician who voted to impose Obamacare on the nation told the reporter that this results from “an honest mistake in drafting.” Sick kids will lose access to medicines because of politicians’ incompetence, but they don’t even bother to defend their not reading or understanding the legislation anymore. Indeed, …

Commentary

Health reform plans represent financial malpractice

Detroit News, February 27, 2010 President Barack Obama has made it clear that reducing the cost of care is one of the primary goals of his reform effort, a point he emphasized at Thursday’s health care summit. And yet, according to a recent report from the Department of Health and …

Commentary

How Stupid Can They Possibly Be?

So who is it this time? Well, it’s those savvy businessmen, wheeling and dealing inside the Beltway, as if the machinations that they arrange with the politicos are actually enforceable. Consider a New York Times report today, beginning with the following: Pressed by industry lobbyists, White House officials on Wednesday …

Commentary

Health Reform Puts Innovation At Risk

Investor’s Business Daily, July 23, 2009 President Obama and congressional Democrats have spelled out few details in their health reform plan. But one thing is certain — it’s going to be expensive. A new report from the Congressional Budget Office puts the price tag of the current proposal from Sen. …

Commentary

The End of Medical Miracles?

Scientific discoveries are neither inevitable nor predictable Americans have, at best, a love-hate relationship with the life-sciences industry—the term for the sector of the economy that produces pharmaceuticals, biologics (like vaccines), and medical devices. These days, the mere mention of a pharmaceutical manufacturer seems to elicit gut-level hostility. Journalists, operating …

Commentary

Don’t Blame Drugs for Health-Care Costs

In the opening pages of his recently released budget, Pres. Barack Obama describes the rising cost of health care as “one of the big drains on family budgets and on the performance of the economy as a whole.” Later in the budget, he suggests that America spends too much on …

Commentary

Big Pharma Accomplishes Big Things, Yet Obama Is Suffocating The Industry

What’s the most research-intensive industry in America? If you guessed Silicon Valley or the energy sector, guess again. In fact, it’s the drug industry. The 31 pharmaceutical companies comprising its main trade group spent $48.5 billion on research and development last year. All told, the pharmaceutical sector has spent $550 …

Commentary

Why Are The Democrats Attacking The Only Successful Part Of Medicare

The much-discussed sequester has taken effect. But federal lawmakers are still trying to find ways to undo the $85 billion in spending cuts it has put in motion. In his state -of-the-union address, President Obama trained his eyes on one of his favorite bogeymen — the pharmaceutical industry. The president …

Commentary

Senior Citizens Will Pay Dearly For Health Care Price Controls

Squabbles over spending cuts have ruled the negotiations over increasing the debt ceiling. But even after the ink is dry on the budget deal just passed, lawmakers will still be charged with reducing federal spending further. One proposal that refuses to die would impose price controls on prescription drugs in …

Commentary

A Plan That Leads Health Care To Nowhere

President Obama recently offered up his plan for cutting the federal budget deficit by $4 trillion over 12 years. A big chunk of those proposed savings–$480 billion, or more than 10%–is supposed to come from federal health care programs. Unfortunately, the president plans to achieve those savings through heavy-handed rationing. …

Commentary

Obamacare Unintended Consequence of the Day: Higher Drug Prices for Kids’ Hospitals

One anonymous politician who voted to impose Obamacare on the nation told the reporter that this results from “an honest mistake in drafting.” Sick kids will lose access to medicines because of politicians’ incompetence, but they don’t even bother to defend their not reading or understanding the legislation anymore. Indeed, …

Commentary

Health reform plans represent financial malpractice

Detroit News, February 27, 2010 President Barack Obama has made it clear that reducing the cost of care is one of the primary goals of his reform effort, a point he emphasized at Thursday’s health care summit. And yet, according to a recent report from the Department of Health and …

Commentary

How Stupid Can They Possibly Be?

So who is it this time? Well, it’s those savvy businessmen, wheeling and dealing inside the Beltway, as if the machinations that they arrange with the politicos are actually enforceable. Consider a New York Times report today, beginning with the following: Pressed by industry lobbyists, White House officials on Wednesday …

Commentary

Health Reform Puts Innovation At Risk

Investor’s Business Daily, July 23, 2009 President Obama and congressional Democrats have spelled out few details in their health reform plan. But one thing is certain — it’s going to be expensive. A new report from the Congressional Budget Office puts the price tag of the current proposal from Sen. …

Commentary

The End of Medical Miracles?

Scientific discoveries are neither inevitable nor predictable Americans have, at best, a love-hate relationship with the life-sciences industry—the term for the sector of the economy that produces pharmaceuticals, biologics (like vaccines), and medical devices. These days, the mere mention of a pharmaceutical manufacturer seems to elicit gut-level hostility. Journalists, operating …

Commentary

Don’t Blame Drugs for Health-Care Costs

In the opening pages of his recently released budget, Pres. Barack Obama describes the rising cost of health care as “one of the big drains on family budgets and on the performance of the economy as a whole.” Later in the budget, he suggests that America spends too much on …

Scroll to Top